---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-017739"
form_type: "8-K"
ticker: "PALI"
cik: "0001357459"
company_name: "PALISADE BIO, INC."
filed_at: "2024-05-03T23:59:59+00:00"
generated_at: "2026-06-02T23:01:26.911396+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Palisade Bio announces $4M private placement of common stock and pre-funded warrants

## Summary
- Gross proceeds of $4M from sale of 615,242 shares/pre-funded warrants at $6.5015 each.
- Issuing 922,863 common warrants with 7-year term at $6.314 per share.
- Ladenburg Thalmann as placement agent; closing on or about May 6, 2024.
- Net proceeds for working capital and general corporate purposes.
- Company to file registration statement for resale within 10 days post-closing.

## SEC filing metadata
- accession: 0001493152-24-017739
- form_type: 8-K
- ticker: PALI
- cik: 0001357459
- company_name: PALISADE BIO, INC.
- filed_at: 2024-05-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357459/000149315224017739/0001493152-24-017739-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357459/000149315224017739/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-017739
- JSON: https://secwatch.observer/filing/0001493152-24-017739.json
- Plain text: https://secwatch.observer/filing/0001493152-24-017739.txt

## Key facts
- Material Agreements
  PALISADE BIO, INC. entered into Purchase Agreement with an institutional investor valued at approximately $4.0 million (effective 2024-05-01).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: an institutional investor
  - Value: approximately $4.0 million
  - Effective: 2024-05-01
  source text: On May 1, 2024, Palisade Bio, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with an institutional investor (the “Purchaser”), pursuant to which the Company agreed to sell and issue, in a private placement, (i) 85,100 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”) and (ii) 530,142 prefunded warrants (the “Prefunded Warrants”) at a purchase price per Share or Prefunded Warrant of $6.5015 (less the applicable exercise price of each Prefunded Warrant purchased) (the “Offering”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357459/000149315224017739/0001493152-24-017739-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.